[Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment].
作者信息
Hulting A L, Muhr C, Lundberg P O, Werner S
机构信息
Endokrinologiska kliniken, Karolinska sjukhuset, Stockholm.
出版信息
Lakartidningen. 1990 Dec 12;87(50):4335-7.
PMID:1980709
Abstract
摘要
相似文献
1
[Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment].男性泌乳素瘤比女性更常见。多巴胺激动剂治疗有效。
Lakartidningen. 1990 Dec 12;87(50):4335-7.
2
[Treatment of prolactinoma with a new dopamine agonist].[新型多巴胺激动剂治疗泌乳素瘤]
Dtsch Med Wochenschr. 1991 Aug 16;116(33):1224-7. doi: 10.1055/s-2008-1063739.
3
[The best approach to treat prolactinoma].[治疗泌乳素瘤的最佳方法]
Gac Med Mex. 2004 Sep-Oct;140(5):567-9.
4
[The treatment of prolactinoma].[催乳素瘤的治疗]
Union Med Can. 1993 Nov-Dec;122(6):496-9.
5
Medical therapy of prolactinomas.催乳素瘤的药物治疗。
Acta Endocrinol (Copenh). 1993 Jul;129 Suppl 1:31-3.
6
Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.催乳素瘤患者对甲氧氯普胺的醛固酮反应：短期溴隐亭治疗的效果
Methods Find Exp Clin Pharmacol. 1996 Nov;18(9):593-7.
7
[Hyperprolactinemia].[高催乳素血症]
Z Arztl Fortbild (Jena). 1991 Feb 25;85(3-4):125-30.
8
Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.用CV 205-502对溴隐亭不耐受的泌乳素瘤患者进行长期治疗。
J Reprod Med. 1994 Jun;39(6):449-54.
9
[Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].溴隐亭长效释放制剂（BrC-LAR）治疗大泌乳素瘤的即刻疗效：附1例报告
Rev Clin Esp. 1992 Jun;191(2):112-3.
10
[Statistical survey of prolactin producing tumor in Japan].[日本催乳素分泌瘤的统计调查]
Nihon Rinsho. 1993 Jan;51 Suppl:33-8.
Zotero 插件